Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.89 USD | +0.09% | +2.09% | +0.33% |
Jun. 06 | Qiagen Scraps NeuMoDx 96, 288 Molecular Systems; Raises 2024 Adjusted Earnings Outlook | MT |
Jun. 06 | Qiagen to Discontinue NeuMoDx Integrated PCR Testing System | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.33% | 9.95B | |
+48.97% | 57.87B | |
+41.65% | 40.25B | |
-6.74% | 39.94B | |
-5.96% | 28.54B | |
+13.15% | 26.4B | |
-20.04% | 19.33B | |
+31.63% | 12.4B | |
+0.51% | 12.23B | |
+25.09% | 12.2B |
- Stock Market
- Equities
- QGEN Stock
- News Qiagen N.V.
- Qiagen Obtains US FDA Clearance for Respiratory Syndromic Testing Panel